Zentiva S.A. — M&A Activity 2018

Feb 15, 2018

Zentiva N.V. is initiating a public offering for the acquisition of Zentiva S.A. (former S.C. Sicomed S.A. – Medicine Plant) shares

Bucharest, February 15th, 2018 – Zentiva N.V. is initiating, between 20.02.2018 – 05.04.2018, a public offering for the acquisition of all the shares outstanding of the company Zentiva S.A. (former S.C. Sicomed S.A. – Medicine Plant) which are not held by it and by the persons acting in concert, namely a number of 76.377.607 shares, accounting for 18.32% of the company's share capital.

BRD – Groupe Société Générale S.A. will act as agent in the stock acquisition public offering.

The acquisition price (price of the offering) for each Zentiva S.A. share is of 3.5 Ron/share.

The persons interested in obtaining additional information can call at 021.302.61.55, the dedicated Public Offering Call Center, or at 021.301.41.52, 021.301.68.73, 021.301.49.81, 021.301.41.55. The document and the announcement of the offering, and also the ASF decision are available on the institutional websites of Zentiva S.A. (www.zentiva.ro), Bucharest Stock Exchange (www.bvb.ro) and BRD - Groupe Société Générale S.A. (www.brd.ro).

The offering document was approved by the Financial Supervisory Authority (ASF) by decision no. 224 of 14.02.2018.

Details about the Public Offering

Offeror – Zentiva N.V., part of Sanofi Group; Issuer – Zentiva S.A.; Agent - BRD – Groupe Societe Generale S.A.

Where to obtain the statement of account?

• BRD Office in 1-7 Ion Mihalache Blvd., Bucharest;
• BRD Unirii Branch Bank, 2 Mircea Vodă Blvd., Bucharest
• One of the agents authorized by ASF. Please find the full list, organized by city, by accessing http://www.bvb.ro/Intermediaries/ListOfIntermediaries/GeneralIndex
• Depozitarul Central S.A. (Central Depository) Bucharest, 34-36 Carol I Blvd., 3rd floor, district 2, phone no. 021.408.58.00

Where to subscribe?

• BRD Office in 1-7 Ion Mihalache Blvd., Bucharest;
• BRD Unirii Branch Bank, 2 Mircea Vodă Blvd., Bucharest
• The office of any authorized agent. The full list, organized by city, is available on http://www.bvb.ro/Intermediaries/ListOfIntermediaries/GeneralIndex

Working hours: throughout the deployment of the offering, during working days between 09.00 and 17.00, except for the closing date of the offering, when the work schedule is between 09.00 and 13.00.

Before subscribing, it is recommended to read the offering document available on the website: www.zentiva.ro, www.brd.ro or www.bvb.ro.

The approval stamp affixed on the offering document does not account for a guarantee or any form of appreciation by ASF concerning the opportunity, advantages or disadvantages, profit or risks that may arise following the transactions to be concluded by

PRESS RELEASE

accepting the public offering subject to the decision of approval. The decision of approval only certifies the conformity of the offering document with the legal requirements and the rules adopted for the enforcement thereof. This offering is solely addressed to Zentiva S.A. shareholders, as per the applicable regulations. Approved by the Financial Supervisory Authority by decision no. 224 of 14.02.2018.

About Zentiva, a Sanofi company

Zentiva is part of Sanofi Group since March 2009. The company's product portfolio covers a wide range of therapeutic areas, with focus on: cardiovascular, inflammatory, pain, infection and CNS disorders, as well as on gastrointestinal and urological disorders.

Media contacts:

Camelia Nitu, Communication Head Sanofi Romania & Moldova 0723.353.520, camelia.nitu@sanofi.com Irina Pătru-Florea, Account Manager Free Communication 0752.111.725, irina.patru@freecomm.ro